論文

査読有り
2020年6月

A Randomized Phase 2 Trial of Antibiotic Prophylaxis Versus No Intervention for Muscle Biopsy in A Neurology Department.

Acta medica Okayama
  • Keiichi Nakahara
  • ,
  • Tokunori Ikeda
  • ,
  • Koutaro Takamatsu
  • ,
  • Nozomu Tawara
  • ,
  • Kentaro Hara
  • ,
  • Yuki Enokida
  • ,
  • Naomi Tanoue
  • ,
  • Sawana Narita
  • ,
  • Akiko Fujii
  • ,
  • Yoshinori Yamanouchi
  • ,
  • Jun Morinaga
  • ,
  • Satoshi Yamashita

74
3
開始ページ
261
終了ページ
264
記述言語
英語
掲載種別
DOI
10.18926/AMO/59961

Muscle biopsy can be used to confirm the diagnosis of neuromuscular diseases. However, it is unclear whether antibiotic prophylaxis prior to muscle biopsy is needed to prevent surgical site infection (SSI). We are conducting a phase 2, single-center, open-labeled, prospective randomized trial to clarify the need for antibiotic prophylaxis in patients at low risk for SSI undergoing muscle biopsy. Patients will be randomized to an antibiotic prophylaxis group or a control group, and the incidence of SSI will be compared between the groups. Our findings will clarify the need for antibiotic prophylaxis in this patient population.

リンク情報
DOI
https://doi.org/10.18926/AMO/59961
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32577026
ID情報
  • DOI : 10.18926/AMO/59961
  • PubMed ID : 32577026

エクスポート
BibTeX RIS